Esprinet Spa: Strong Performance and Positive Outlook Drive Buy Rating and Target Price IncreaseWe reiterate our positive view and raise our TP to €6.70 (from €6.30) following the revision of estimates. 2Q results beat expectations, reflecting a significant quarterly improvement. Sales were €969mn (+5% YoY), slightly ahead of our €951mn, highlighting further rising performances in the value-added segments, with Solutions up 16% , along with a solid increase for the recently launched green tech division a resilient performance by the Screens division (+4%). The negative market stance continued for the Devices segment (down -6%), still suffering from softer demand. By geography, Italy was up slightly (+3%), while (€19mn) saw healthy growth. By customer type, B2C sales (retailer/e-tailer) were down -9%, whereas the B2B segment (IT reseller) saw a +8% increase, accelerating QoQ.